Blog - Page 927 of 5700 - QualityStocks

MondayJul 25, 2022 1:34 pm

QualityStocksNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) Leveraging Sapientus Division to Expand into Big Data Services

FingerMotion (NASDAQ: FNGR) is building a deeper channel for revenue in its services for China’s mobile phone users and big data clients. “FingerMotion’s central competencies are in mobile payment and mobile recharge platform solutions, but the company has been expanding into big data services through its Sapientus division. The data services have primarily been marketed as a tool for reinsurance companies as they look for effective measures of risk scoring and ways to simplify policy underwiring purchasing, but FingerMotion has acknowledged it could expand into other industries in the future,” a recent article reads. FingerMotion CEO Martin Shen is quoted…

MondayJul 25, 2022 1:23 pm

QualityStocksNewsBreaks – Why Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTF) (FRA: 7HIA) Is ‘One to Watch’

Hillcrest (CSE: HEAT) (OTCQB: HLRTF) (FRA: 7HIA), a Vancouver, British Columbia-based company, is engaged in developing high-performance power conversion technologies and digital control systems for next-generation powertrains and grid-connected renewable energy systems. “Hillcrest power inverter technology helps produce efficiencies in electrification and maximize the performance of electric systems, including electric vehicles (“EVs”), motors and generators. The company offers a flexible, single-inverter architecture that can be applied at nearly every stage of the electrification ecosystem, from renewable energy generation through the charging and operation of an EV, to provide full-cycle efficiency and performance improvements,” a recent article reads. “Hillcrest’s first application…

MondayJul 25, 2022 12:45 pm

Cub Crafters Inc. Is ‘One to Watch’

CubCrafters owns 15 undeveloped acres at McAllister Field for potential expansion of operations The company recently opened a new 11,000-square-foot Customer Completion Center Cost and timeline of FAA Certification represents a significant barrier to entry The company introduced its CC19-180 XCub aircraft in June 2016, completing the six-year project without using any outside investment The company recently released new variants of the XCub offering floats and more engine horsepower New nosewheel configurations open up the company’s product line to 85% of all pilots Only 10-12% of CubCrafter’s sales are international, though it represents 50% of the market demand – an…

MondayJul 25, 2022 12:42 pm

QualityStocksNewsBreaks – DPCM Capital Inc.’s (NYSE: XPOA) Pending SPAC Merger Target D-Wave Forms Alliance with Mastercard (NYSE: MA) to Champion Quantum Computing Solutions

DPCM Capital (NYSE: XPOA) recently entered into a definitive transaction agreement with D-Wave Systems Inc., whereby, upon closing of the transaction, shares of the pending parent company – D-Wave Quantum Inc. – are expected to trade on the NYSE under ticker symbol QBTS. D-Wave Systems, a leader in quantum computing systems, software and services, and the only company building both quantum annealing and gate-based quantum computers, and Mastercard (NYSE: MA) recently announced a multi-year strategic alliance to champion the acceleration and adoption of quantum computing solutions. According to the announcement, D-Wave and Mastercard will collaborate on the research and development…

MondayJul 25, 2022 12:16 pm

QualityStocksNewsBreaks – Correlate Infrastructure Partners Inc. (CIPI) Signs LOI to Acquire Leading Solar, Storage Platform

Correlate Infrastructure Partners (OTCQB: CIPI), a technology-enabled energy optimization and clean-energy solutions provider for North America, has entered into a nonbinding letter of intent (“LOI”) outlining its plans to acquire a top-10 solar, battery storage and roofing provider based in California. According to the announcement, the target company focuses on sales and self-performance construction of solar and roofing services for residential and commercial properties; CIPI anticipates the acquisition to be complete and accretive by the second half of this year, marking the “next evolution” of the company as a community-scale distributed energy company. Highlights of the agreement include expanded national…

MondayJul 25, 2022 12:04 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Urges Shareholders to Vote in Favor of Proxy Proposals for Upcoming Annual Meeting

CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system. The company today urged shareholders to vote in favor of the proposals outlined in its definitive proxy statement for the upcoming annual shareholder meeting to be held Wednesday, July 27, 2022. Proposals include the authorization to increase the number of shares available for issuance by the company and the authorization for the board of directors to effect a reverse stock split of the outstanding shares of the company’s common stock, at a split…

MondayJul 25, 2022 12:00 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Receives Notice of Allowance of 26th Worldwide Patent

Lexaria, a global innovator in drug delivery technology, has developed the patented DehydraTECH(TM) technology which has been the subject of several issued patents Recently, Lexaria reported it had been notified of the allowance of its 26th worldwide patent with a new patent to be granted in Japan The patent is the fourth to be granted in Japan and the first patent issued from Lexaria’s seventh patent family Lexaria also submitted a briefing book to the FDA to facilitate its upcoming pre-Investigational New Drug (“IND”) meeting with the agency “We are extremely pleased to have received our first patent protecting our…

MondayJul 25, 2022 11:52 am

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Issues Update on Phase 2 EB Trial

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, today provided an update on its phase 2 clinical trial using investigational drug INM-755 cannabinol (“CBN”) cream for the treatment of patients with epidermolysis bullosa (“EB”). Based on safety data of the first five adult patients who completed the phase 2 study, an independent data monitoring committee agreed it is safe to allow the enrollment of adolescent patients, defined as persons aged twelve to seventeen with EB. “We are pleased that the initial safety data from InMed’s phase 2 EB clinical trial has allowed…

MondayJul 25, 2022 11:22 am

QualityStocksNewsBreaks – Friendable Inc. (FDBL) Launches Revamped ‘Song of the Summer’ Contest

Friendable (OTC: FDBL), a mobile technology and marketing company, today announced its “Song of the Summer” contest and artist promotion. According to the update, the submission process opened to artists last week as the company received an immediate positive response with entries pouring in. The contest registration will remain open until July 31, 2022, and fan voting will begin in August 2022 to determine each of the five winners per genre. “This contest has been a highly sought after and anticipated promotion since it began with the former Artist Republik management team,” said Friendable CEO Robert A. Rositano Jr. “Now…

MondayJul 25, 2022 11:15 am

Silo Pharma Inc. (SILO) Produced Initial Liposome Batch for Rheumatoid Arthritis Study

Silo Pharma produced initial batch of SPU-21 liposomes for rheumatoid arthritis study conducted by CRO Frontage Laboratories Recent company research revealed SPU-21 liposomes can target inflamed epithelium, suggesting use for targeted drug delivery SPU-21 can be used for development of fusion imaging molecules and/or nanoparticles to study arthritic pathogenesis Company recently announced positive results in subcutaneous delivery of novel liposomes vs. intravenous injection Silo Pharma (OTCQB: SILO), a developmental stage biopharmaceutical company that focuses on fusing traditional therapeutics with psychedelic research, recently announced it had produced an initial batch of SPU-21 liposomes for a rheumatoid arthritis study conducted by Frontage…

Site Search

Company Search